Northern Mindanao: Police in Northern Mindanao have activated a 24/7 Media Action Center and intensified anti-vote-buying operations ahead of Monday’s elections, officials announced Thursday. Police Regional Office 10 director, Brig. Gen. Jaysen de Gu…
Author: lwadmin
Capiz Completes Testing and Sealing of 773 Automated Counting Machines Ahead of Elections
Capiz: The Commission on Elections (Comelec) in Capiz has completed the final testing and sealing (FTS) of all 773 automated counting machines (ACMs) designated for the province’s clustered precincts ahead of the May 12 national and local elections. C…
Bank Lending and Domestic Liquidity Experience Growth in March
Manila: Bank lending continued to post double-digit growth while domestic liquidity expanded by more than 6 percent in March, the Bangko Sentral ng Pilipinas (BSP) said. Preliminary data released on Thursday showed that outstanding loans of universal …
Comelec Disqualifies Pasig Congressional Candidate Sia Over Offensive Remarks
Manila: The Commission on Elections’ (Comelec) Second Division has disqualified Pasig congressional candidate Christian Sia from the May 2025 elections following his inappropriate comments about single mothers during a campaign event last month.
Acc…
Zoom and ServiceNow Announce Strategic Integration to Elevate Customer and Employee Experiences
Unified Engagement from Zoom CX and ServiceNow integrates voice, video, and digital channels directly within the ServiceNow AI Platform for a simpler agent experience and more personalized customer engagements LAS VEGAS, May 07, 2025 (GLOBE NEWSWIRE) — Zoom Communications Inc. (NASDAQ: ZM) and ServiceNow (NYSE: NOW), the AI platform for business transformation, today announced plans […]
Dr. Falk Pharma announces positive results from its pivotal phase 3 trial on norucholic acid in primary sclerosing cholangitis
Freiburg, May 7th, 2025 Study results demonstrate superiority of norucholic acid (NCA) over placebo in the combined primary endpoint. There is currently no approved medicine to treat primary sclerosing cholangitis. The results of the 96-week analysis of the NUC-5 trial will be presented at 2025 EASL Congress in Amsterdam. Dr. Falk Pharma, a research-based pharmaceutical […]